Kidney transplantation is the preferred therapy for the majority of patients with end stage renal disease because overall survival and quality of life are better than with hemodialysis44, 45; hence reduced serum levels of AOPP-albumin as well as tissue factor might be one of the factors contributing to the decreased cardiovascular mortality of kidney transplant patients. The gene discussed is ALB; the disease is chronic kidney disease.